Forbes - The quiet national vaccine pass

Plus: Canada ends emergency declaration sparked by convoy protests

Intrivo announced today that its On/Go One at-home test for Covid received emergency use authorization from the FDA. The test was developed by ACON Laboratories and both companies say that it boasts a 98% accuracy percentage. It’s the second at-home Covid test that Intrivo is distributing, both of which pair with the company’s mobile app. It’s also the 15th at-home antigen test that’s been granted an EUA by the FDA. The interesting question that remains is that as the omicron wave subsides, if there’s not another surge of Covid nationwide, how large will the market for these products remain? There are at-home tests for a wide variety of ailments, so there might be steady sales. Only time will tell.   

Do you have comments or questions? Email us at health@forbes.com

More Covid News

Queen Elizabeth II postponed her two virtual events scheduled for Thursday, the second time she has done so since she tested positive for coronavirus earlier this week.

All remaining pandemic restrictions in England were lifted today, and the country will dismantle its free Covid testing system by April.

Omicron quickly became the most dominant global variant of Covid - what can be expected from it moving forward? 

Politicians are making a lot of hay with the concept of endemic Covid, but it may not mean what they think it means.

What Else We Are Reading

• Will a rising Omicron variant scramble antibody treatments? (Nature)

• Chewing Gum with GMO Could Reduce the Spread of COVID (Scientific American)

• We Might Not Need Annual COVID Shots (The Atlantic)